JP Patent

JP2018529707A — 嚢胞性線維症の処置のための新規な化合物

Assigned to Galapagos NV · Expires 2018-10-11 · 8y expired

What this patent protects

嚢胞性線維症の処置において有用な、新たに合成された嚢胞性線維症膜貫通コンダクタンス調節因子（ＣＦＴＲ）タンパク質を安定化できるコレクター薬剤。

USPTO Abstract

嚢胞性線維症の処置において有用な、新たに合成された嚢胞性線維症膜貫通コンダクタンス調節因子（ＣＦＴＲ）タンパク質を安定化できるコレクター薬剤。

Drugs covered by this patent

Patent Metadata

Patent number
JP2018529707A
Jurisdiction
JP
Classification
—
Expires
2018-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Galapagos NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.